Literature DB >> 11047757

A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO).

J Zonana1, M E Elder, L C Schneider, S J Orlow, C Moss, M Golabi, S K Shapira, P A Farndon, D W Wara, S A Emmal, B M Ferguson.   

Abstract

Hypohidrotic ectodermal dysplasia (HED), a congenital disorder of teeth, hair, and eccrine sweat glands, is usually inherited as an X-linked recessive trait, although rarer autosomal dominant and recessive forms exist. We have studied males from four families with HED and immunodeficiency (HED-ID), in which the disorder segregates as an X-linked recessive trait. Affected males manifest dysgammaglobulinemia and, despite therapy, have significant morbidity and mortality from recurrent infections. Recently, mutations in IKK-gamma (NEMO) have been shown to cause familial incontinentia pigmenti (IP). Unlike HED-ID, IP affects females and, with few exceptions, causes male prenatal lethality. IKK-gamma is required for the activation of the transcription factor known as "nuclear factor kappa B" and plays an important role in T and B cell function. We hypothesize that "milder" mutations at this locus may cause HED-ID. In all four families, sequence analysis reveals exon 10 mutations affecting the carboxy-terminal end of the IKK-gamma protein, a domain believed to connect the IKK signalsome complex to upstream activators. The findings define a new X-linked recessive immunodeficiency syndrome, distinct from other types of HED and immunodeficiency syndromes. The data provide further evidence that the development of ectodermal appendages is mediated through a tumor necrosis factor/tumor necrosis factor receptor-like signaling pathway, with the IKK signalsome complex playing a significant role.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11047757      PMCID: PMC1287930          DOI: 10.1086/316914

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  33 in total

1.  RANK is essential for osteoclast and lymph node development.

Authors:  W C Dougall; M Glaccum; K Charrier; K Rohrbach; K Brasel; T De Smedt; E Daro; J Smith; M E Tometsko; C R Maliszewski; A Armstrong; V Shen; S Bain; D Cosman; D Anderson; P J Morrissey; J J Peschon; J Schuh
Journal:  Genes Dev       Date:  1999-09-15       Impact factor: 11.361

Review 2.  The IKK complex: an integrator of all signals that activate NF-kappaB?

Authors:  A Israël
Journal:  Trends Cell Biol       Date:  2000-04       Impact factor: 20.808

3.  [Polysaccharide specific humoral immunodeficiency in ectodermal dysplasia. Case report of a boy with two affected brothers].

Authors:  P Schweizer; H Kalhoff; G Horneff; V Wahn; L Diekmann
Journal:  Klin Padiatr       Date:  1999 Nov-Dec       Impact factor: 1.349

4.  IKKgamma serves as a docking subunit of the IkappaB kinase (IKK) and mediates interaction of IKK with the human T-cell leukemia virus Tax protein.

Authors:  E W Harhaj; S C Sun
Journal:  J Biol Chem       Date:  1999-08-13       Impact factor: 5.157

5.  Involvement of a novel Tnf receptor homologue in hair follicle induction.

Authors:  D J Headon; P A Overbeek
Journal:  Nat Genet       Date:  1999-08       Impact factor: 38.330

6.  Ectodysplasin is a collagenous trimeric type II membrane protein with a tumor necrosis factor-like domain and co-localizes with cytoskeletal structures at lateral and apical surfaces of cells.

Authors:  S Ezer; M Bayés; O Elomaa; D Schlessinger; J Kere
Journal:  Hum Mol Genet       Date:  1999-10       Impact factor: 6.150

7.  Severe liver degeneration and lack of NF-kappaB activation in NEMO/IKKgamma-deficient mice.

Authors:  D Rudolph; W C Yeh; A Wakeham; B Rudolph; D Nallainathan; J Potter; A J Elia; T W Mak
Journal:  Genes Dev       Date:  2000-04-01       Impact factor: 11.361

8.  TTRAP, a novel protein that associates with CD40, tumor necrosis factor (TNF) receptor-75 and TNF receptor-associated factors (TRAFs), and that inhibits nuclear factor-kappa B activation.

Authors:  S Pype; W Declercq; A Ibrahimi; C Michiels; J G Van Rietschoten; N Dewulf; M de Boer; P Vandenabeele; D Huylebroeck; J E Remacle
Journal:  J Biol Chem       Date:  2000-06-16       Impact factor: 5.157

9.  Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium.

Authors:  A Smahi; G Courtois; P Vabres; S Yamaoka; S Heuertz; A Munnich; A Israël; N S Heiss; S M Klauck; P Kioschis; S Wiemann; A Poustka; T Esposito; T Bardaro; F Gianfrancesco; A Ciccodicola; M D'Urso; H Woffendin; T Jakins; D Donnai; H Stewart; S J Kenwrick; S Aradhya; T Yamagata; M Levy; R A Lewis; D L Nelson
Journal:  Nature       Date:  2000-05-25       Impact factor: 49.962

Review 10.  It's got you covered. NF-kappaB in the epidermis.

Authors:  C K Kaufman; E Fuchs
Journal:  J Cell Biol       Date:  2000-05-29       Impact factor: 10.539

View more
  117 in total

1.  Finding NEMO: genetic disorders of NF-[kappa]B activation.

Authors:  Jordan S Orange; Raif S Geha
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

Review 2.  NF-kappaB family of transcription factors: central regulators of innate and adaptive immune functions.

Authors:  Jorge Caamaño; Christopher A Hunter
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

Review 3.  NF-kappaB in critical diseases: a bad guy?

Authors:  Uwe Senftleben
Journal:  Intensive Care Med       Date:  2003-09-04       Impact factor: 17.440

4.  Non-functional immunoglobulin G transcripts in a case of hyper-immunoglobulin M syndrome similar to type 4.

Authors:  John M Darlow; Alex M Farrell; David I Stott
Journal:  Immunology       Date:  2004-02       Impact factor: 7.397

5.  Correlating interleukin-12 stimulated interferon-γ production and the absence of ectodermal dysplasia and anhidrosis (EDA) in patients with mutations in NF-κB essential modulator (NEMO).

Authors:  Margje H Haverkamp; Beatriz E Marciano; David M Frucht; Ashish Jain; Esther van de Vosse; Steven M Holland
Journal:  J Clin Immunol       Date:  2014-02-28       Impact factor: 8.317

6.  Mutation identification in a canine model of X-linked ectodermal dysplasia.

Authors:  Margret L Casal; Jennifer L Scheidt; James L Rhodes; Paula S Henthorn; Petra Werner
Journal:  Mamm Genome       Date:  2005-07       Impact factor: 2.957

7.  Impaired dendritic-cell function in ectodermal dysplasia with immune deficiency is linked to defective NEMO ubiquitination.

Authors:  Stephane T Temmerman; Chi A Ma; Louis Borges; Marek Kubin; Shuying Liu; Jonathan M J Derry; Ashish Jain
Journal:  Blood       Date:  2006-06-22       Impact factor: 22.113

8.  Specific NEMO mutations impair CD40-mediated c-Rel activation and B cell terminal differentiation.

Authors:  Ashish Jain; Chi A Ma; Eduardo Lopez-Granados; Gary Means; William Brady; Jordan S Orange; Shuying Liu; Steven Holland; Jonathan M J Derry
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

9.  ORAI1 deficiency and lack of store-operated Ca2+ entry cause immunodeficiency, myopathy, and ectodermal dysplasia.

Authors:  Christie-Ann McCarl; Capucine Picard; Sara Khalil; Takumi Kawasaki; Jens Röther; Alexander Papolos; Jeffery Kutok; Claire Hivroz; Francoise Ledeist; Katrin Plogmann; Stephan Ehl; Gundula Notheis; Michael H Albert; Bernd H Belohradsky; Janbernd Kirschner; Anjana Rao; Alain Fischer; Stefan Feske
Journal:  J Allergy Clin Immunol       Date:  2009-12       Impact factor: 10.793

Review 10.  Kinase mutations in human disease: interpreting genotype-phenotype relationships.

Authors:  Piya Lahiry; Ali Torkamani; Nicholas J Schork; Robert A Hegele
Journal:  Nat Rev Genet       Date:  2010-01       Impact factor: 53.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.